Cytokinetics, Incorporated (CYTK)

NASDAQ: CYTK · Real-Time Price · USD

62.22

-0.41 (-0.65%)

At close: Feb 27, 2026, 4:00 PM EST

62.00

-0.22 (-0.35%)

After-hours: Feb 27, 2026, 7:28 PM EST

Cytokinetics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	882.22	94.86	113.02	65.58	112.67
Short-Term Investments	-	981.16	501.8	717	358.97
Cash & Short-Term Investments	882.22	1,076	614.82	782.58	471.64
Cash Growth	-18.01%	75.01%	-21.44%	65.93%	1.63%
Accounts Receivable	-	16.65	1.28	0.15	56.82
Receivables	-	16.65	1.28	0.15	56.82
Prepaid Expenses	-	15.28	11.94	12.46	7.22
Other Current Assets	34.75	-	-	-	-
Total Current Assets	916.98	1,108	628.05	795.19	535.67
Property, Plant & Equipment	155.17	140.97	147.74	163.19	146.41
Long-Term Investments	335.05	145.06	40.53	46.71	152.05
Other Long-Term Assets	17.34	7.71	8	9.69	7.19
Total Assets	1,425	1,402	824.32	1,015	841.32
Accounts Payable	105.62	20.37	21.51	25.61	21.09
Accrued Expenses	-	55.32	42.64	44.1	34.37
Short-Term Debt	31.1	11.3	-	-	-
Current Portion of Long-Term Debt	41.18	11.52	10.08	0.96	-
Current Portion of Leases	19.11	19.18	17.89	12.83	14.86
Current Unearned Revenue	1.61	52.37	-	-	-
Other Current Liabilities	3.83	9.61	10.56	1.12	1.54
Total Current Liabilities	202.45	179.67	102.68	84.62	71.86
Long-Term Debt	1,253	768.6	607.37	609.62	142.84
Long-Term Leases	107.97	112.58	120.43	126.9	112.23
Long-Term Unearned Revenue	520.56	462.19	379.98	300.5	266.07
Other Long-Term Liabilities	-	14	0.19	1.04	4.46
Total Liabilities	2,084	1,537	1,211	1,123	597.46
Common Stock	0.12	0.12	0.1	0.09	0.08
Additional Paid-In Capital	2,826	2,564	1,726	1,482	1,452
Retained Earnings	-3,487	-2,702	-2,112	-1,586	-1,208
Comprehensive Income & Other	0.63	2.4	-0.01	-3.59	-0.87
Shareholders' Equity	-659.63	-135.37	-386.32	-107.9	243.86
Total Liabilities & Equity	1,425	1,402	824.32	1,015	841.32
Total Debt	1,453	923.18	755.77	750.3	269.93
Net Cash (Debt)	-570.32	152.83	-140.95	32.28	201.71
Net Cash Growth	-	-	-	-84.00%	-37.96%
Net Cash Per Share	-4.75	1.36	-1.46	0.36	2.62
Filing Date Shares Outstanding	120.1	118.41	103	95.16	84.86
Total Common Shares Outstanding	120.1	118.21	101.64	94.83	84.8
Working Capital	714.52	928.27	525.37	710.57	463.81
Book Value Per Share	-5.49	-1.15	-3.80	-1.14	2.88
Tangible Book Value	-659.63	-135.37	-386.32	-107.9	243.86
Tangible Book Value Per Share	-5.49	-1.15	-3.80	-1.14	2.88
Machinery	-	30.82	28.16	28.45	27.48
Construction In Progress	-	4.07	0.22	0.74	0.22
Leasehold Improvements	-	66.87	66.87	65.91	60.34

Updated Feb 24, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q